AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+9.75%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(-0.95%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-10.77%
Top 10 Holdings %
Top 10 Hldgs %
21.49%
Holding
245
New
28
Increased
32
Reduced
137
Closed
15
Top Buys
| 1 |
Merck
MRK
|
$2.73M |
| 2 |
Indivior
INDV
|
$2.36M |
| 3 |
Alphatec Holdings
ATEC
|
$2.06M |
| 4 |
Neurocrine Biosciences
NBIX
|
$1.79M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$1.37M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$4.17M |
| 2 |
Pacira BioSciences
PCRX
|
$3.36M |
| 3 |
Pfizer
PFE
|
$3.04M |
| 4 |
United Therapeutics
UTHR
|
$2.96M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$2.13M |
Sector Composition
| 1 | Healthcare | 57.92% |
| 2 | Real Estate | 14.45% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 3.2% |
| 5 | Technology | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Keros Therapeutics
KROS
$640M
| $465K | 0.35% |
+8,000
| New | +$465K |
|
77
Medtronic
MDT
$118B
| $450K | 0.33% |
5,000
-12,500
| -71% | -$1.13M |
|
78
Costco
COST
$421B
| $442K | 0.33% |
499
-35
| -7% | -$31K |
|
79
Republic Services
RSG
$72.6B
| $406K | 0.3% |
2,020
-138
| -6% | -$27.7K |
|
80
Arch Capital
ACGL
$34.7B
| $401K | 0.3% |
3,587
-123
| -3% | -$13.8K |
|
81
Loews
L
$20.1B
| $392K | 0.29% |
4,953
-273
| -5% | -$21.6K |
|
82
JPMorgan Chase
JPM
$824B
| $380K | 0.28% |
1,800
-84
| -4% | -$17.7K |
|
83
iShares 7-10 Year Treasury Bond ETF
IEF
$35.6B
| $375K | 0.28% |
3,823
-365
| -9% | -$35.8K |
|
84
iShares 3-7 Year Treasury Bond ETF
IEI
$16.8B
| $374K | 0.28% |
3,126
-1,060
| -25% | -$127K |
|
85
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $373K | 0.28% |
4,482
-2,534
| -36% | -$211K |
|
86
SPDR Bloomberg Convertible Securities ETF
CWB
$4.39B
| $370K | 0.28% |
4,834
-91
| -2% | -$6.97K |
|
87
iShares Preferred and Income Securities ETF
PFF
$14.4B
| $370K | 0.28% |
11,136
-21
| -0.2% | -$698 |
|
88
iShares JPMorgan EM High Yield Bond ETF
EMHY
$492M
| $367K | 0.27% |
9,401
-45
| -0.5% | -$1.76K |
|
89
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.4B
| $366K | 0.27% |
3,908
-65
| -2% | -$6.08K |
|
90
Insmed
INSM
$30.3B
| $365K | 0.27% |
+5,000
| New | +$365K |
|
91
Vanguard High Dividend Yield ETF
VYM
$63.6B
| $361K | 0.27% |
2,815
-121
| -4% | -$15.5K |
|
92
Invesco S&P 500 BuyWrite ETF
PBP
$290M
| $361K | 0.27% |
15,794
-229
| -1% | -$5.23K |
|
93
SPDR S&P International Dividend ETF
DWX
$486M
| $360K | 0.27% |
9,375
-589
| -6% | -$22.6K |
|
94
Dyne Therapeutics
DYN
$1.92B
| $359K | 0.27% |
10,000
-10,000
| -50% | -$359K |
|
95
Invesco Senior Loan ETF
BKLN
$6.97B
| $358K | 0.27% |
17,016
+333
| +2% | +$7K |
|
96
iShares Mortgage Real Estate ETF
REM
$602M
| $354K | 0.26% |
14,926
+745
| +5% | +$17.7K |
|
97
Delta Air Lines
DAL
$40B
| $353K | 0.26% |
6,951
-214
| -3% | -$10.9K |
|
98
ArriVent BioPharma
AVBP
$781M
| $353K | 0.26% |
15,000
-71,000
| -83% | -$1.67M |
|
99
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $343K | 0.26% |
330,000
-670,000
| -67% | -$697K |
|
100
Viridian Therapeutics
VRDN
$1.59B
| $341K | 0.25% |
15,000
+2,500
| +20% | +$56.9K |
|